Welcome
Login / Register

Assessing the Role of Emerging Therapies in the Management of Acid Sphingomyelinase Deficiency

Thanks! Share it with your friends!

URL

You disliked this video. Thanks for the feedback!

Sorry, only registred users can create playlists.
URL


Added by Admin in high quality
0 Views

Description

Co-Chairs, Robin Lachmann, MD, PhD, and Melissa Wasserstein, MD, discuss acid sphingomyelinase deficiency in this CME activity titled “Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency.” For the full presentation, downloadable Practice Aids and slides, complete CME information, and to apply for credit, please visit us at PeerView.com/NPH865. CME credit will be available until June 3, 2021.

Post your comment

Comments

Be the first to comment
RSS